Specialists for Chronic lymphoproliferative disorder of natural killer cells

51 physicians and care centers identified from ClinicalTrials.gov trial PIs, PubMed publications, and the NPPES NPI registry.

ℹ

Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.

Report missing data

Katherine Hsu, MD, PhD
Rare Disease / Clinical Research
Memorial Sloan Kettering Cancer Center
QC-verified PI×1
Ann Alice Jakubowski, MD, PhD, MD
Rare Disease / Clinical Research
Memorial Sloan Kettering Cancer Center
NEW YORK, NY
QC-verified PI×1
Wing Leung, MD, PhD
Rare Disease / Clinical Research
St. Jude Children's Research Hospital
QC-verified PI×1
Yuki Fukami
Rare Disease / Clinical Research
Nagoya University Graduate School of Medicine
QC-verified 1
Andrea Rivero
Rare Disease / Clinical Research
Hospital Clínic
ALEXANDRIA, VA
QC-verified 1
Masahisa Katsuno
Rare Disease / Clinical Research
Nagoya University Graduate School of Medicine
QC-verified 1
Dolors Colomer
Rare Disease / Clinical Research
Hospital Clínic
QC-verified 1
Mónica López-Guerra
Rare Disease / Clinical Research
Hospital Clínic
QC-verified 1
Laura Jiménez
Rare Disease / Clinical Research
Hospital Clínic
QC-verified 1
Pablo Mozas
Rare Disease / Clinical Research
Hospital Clínic
QC-verified 1
Ichiro Yabe
Rare Disease / Clinical Research
Faculty of Medicine and Graduate School of Medicine
QC-verified 1
Kazuki Yamada
Rare Disease / Clinical Research
Hakodate Municipal Hospital
QC-verified 1
Takashi Inoue
Rare Disease / Clinical Research
Faculty of Medicine and Graduate School of Medicine
QC-verified 1
Shuntaro Nakamura
Rare Disease / Clinical Research
Hakodate Municipal Hospital
QC-verified 1
Kazuhiro Horiuchi
Rare Disease / Clinical Research
Hakodate Municipal Hospital
QC-verified 1
Yutaka Tsutsumi
Rare Disease / Clinical Research
Hakodate Municipal Hospital
QC-verified 1
Satoru Munakata
Rare Disease / Clinical Research
Hakodate Municipal Hospital
QC-verified 1
Satoru Yagi
Rare Disease / Clinical Research
Nagoya University Graduate School of Medicine
QC-verified 1
Brenda Sandmaier
Rare Disease / Clinical Research
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
SEATTLE, WA
PI×18
Kyoo H. Lee, MD
Rare Disease / Clinical Research
Asan Medical Center
PI×8
Steven Horwitz, MD
Rare Disease / Clinical Research
Memorial Sloan Kettering Cancer Center
PI×4
Thomas C. Shea, MD
Rare Disease / Clinical Research
UNC Lineberger Comprehensive Cancer Center
PI×5
Punita Grover, MD, MBBS
Rare Disease / Clinical Research
Masonic Cancer Center, University of Minnesota
STANFORD, CA
PI×1
David Shook, MD
Rare Disease / Clinical Research
Nkarta, Inc.
PI×4
Nashat Gabrail, MD, M.D
Rare Disease / Clinical Research
Gabrail Cancer Center Research
CANTON, OH
PI×2
Veronika Bachanova, MD, MD
Rare Disease / Clinical Research
Masonic Cancer Center, University of Minnesota
MINNEAPOLIS, MN
PI×5
Brandon Triplett, MD, MD
Rare Disease / Clinical Research
St. Jude Children's Research Hospital
MEMPHIS, TN
PI×5
Chitra M. Hosing, MD, M.D
Rare Disease / Clinical Research
M.D. Anderson Cancer Center
HOUSTON, TX
PI×6
Thomas A Waldmann, M.D.
Rare Disease / Clinical Research
National Cancer Institute (NCI)
PI×6
Richard W Childs, M.D.
Rare Disease Specialist
National Heart, Lung, and Blood Institute (NHLBI)
Bethesda, Maryland
PI×7
Michael Hallek, MD
Rare Disease / Clinical Research
German CLL Study Group, Department I of Internal Medicine University Hospital Cologne
PI×8
Nadège Corradini, MD
Rare Disease / Clinical Research
Nantes University Hospital
PI×2
Patrice Chevallier, MD
Rare Disease / Clinical Research
Nantes University Hospital
PI×3
Shuhua Yi, Doctor
Rare Disease / Clinical Research
Institute of Hematology & Blood Diseases Hospital, China
PI×2
Najla El Jurdi, MD
Rare Disease / Clinical Research
Masonic Cancer Center, University of Minnesota
PI×2
Margaret MacMillan, MD, MSC
Rare Disease / Clinical Research
University of Minnesota
PI×1 2
Stefano Tarantolo, MD, M.D
Rare Disease / Clinical Research
Nebraska Cancer Specialists
OMAHA, NE
PI×1
Daniel Kerr, MD
Rare Disease / Clinical Research
ASCLEPES Research Centers
PI×1
Tamra Slone, MD
Rare Disease / Clinical Research
U Texas SouthWestern
WILMINGTON, OH
PI×1
Paul Rubinstein, MD
Rare Disease / Clinical Research
University of Illinois at Chicago
PALO ALTO, CA
PI×1
Lasika Seneviratne, MD, M.D
Rare Disease / Clinical Research
Los Angeles Cancer Network
LOS ANGELES, CA
PI×1
Gary Schiller, MD, md
Rare Disease / Clinical Research
University of California, Los Angeles
LOS ANGELES, CA
PI×1 1
Don Stevens, MD
Rare Disease / Clinical Research
Norton Cancer Institute
PI×1
Pamela Miel, MD
Rare Disease / Clinical Research
Innovative Clinical Research Institute
PI×1
Salil Goorha, MD, M.D
Rare Disease / Clinical Research
Memphis Baptist Cancer Center
MEMPHIS, TN
PI×1
Elizabeth Budde, MD, LCSW
Rare Disease / Clinical Research
City of Hope Medical Center
CHICAGO, IL
PI×1
Loretta Nastoupil, MD, M.D
Rare Disease / Clinical Research
M.D. Anderson Cancer Center
HOUSTON, TX
PI×1 1
David Wald, MD, PhD
Rare Disease / Clinical Research
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
PI×1
Thérèse AURRAN-SCHLEINITZ, MD
Rare Disease / Clinical Research
Institut Paoli-Calmettes
PI×1
Françoise Mechinaud, md
Rare Disease / Clinical Research
Nantes University Hospital
PI×1
Norbert Ifrah, MD
Rare Disease / Clinical Research
University Hospital, Angers
PI×1

More about Chronic lymphoproliferative disorder of natural killer cells

Disease overview →
Treatments →
Clinical trials →